by South Australian Health and Medical Research Institute (SAHMRI) Credit: Shutterstock New research from the Registry of Senior Australians (ROSA) at SAHMRI has linked medication reviews to a lower risk of death for aged care residents. The study, led by Dr. Janet Sluggett and funded by the Australian Association of Consultant Pharmacy (AACP), followed 57,719...
by Flinders University Credit: Pixabay/CC0 Public Domain Fewer than 3% of people with mental health conditions living in Australian residential aged care facilities accessed government-subsidized mental health services, a new analysis from Flinders University and the South Australian Health and Medical Research Institute (SAHMRI) has found, with calls for organizational and policy changes to improve...
by University of California – San Diego Over the last three decades, meaning in life has emerged as an important question in medical research, especially in the context of an aging population. A recent study by researchers at University of California San Diego School of Medicine found that the presence of and search for meaning...
by David Murphy, Aedin Ni Loingsigh, Ingeborg Birnie and Thomas H Bak, The Conversation For many people with dementia, memories of early childhood appear more vivid than their fragile sense of the present. But what happens when the present is experienced through a different language than the one spoken in childhood? And how might carers...
by IOS Press In order to optimally treat motor symptoms in patients with Parkinson’s disease (PD), it is necessary to have a good understanding of their severity and daily fluctuations. A report in the Journal of Parkinson’s Disease describes how a new app, SleepFit, could be a useful tool in routine clinical practice to monitor...
MAYO CLINIC JACKSONVILLE, Fla. — Despite decades of scientific scrutiny, Alzheimer’s disease researchers have yet to work out its cause or treatment. Understanding what underlies its three distinct subtypes is thought to be a promising new research avenue. In a new study in JAMA Neurology, a team of neuroscientists at Mayo Clinic in Florida led...
By MATTHEW HERPER @matthewherper OCTOBER 22, 2019 In a shocking reversal, Biogen (BIIB) on Tuesday said that it would resurrect an Alzheimer’s drug that the company previously said had failed and will ask the Food and Drug Administration to approve it. The company said a “new analysis of larger dataset” showed that the drug, aducanumab,...
By Catharine Paddock PhD Fact checked by Carolyn Robertson Scientists have identified gene variants that appear able to alter the risk of Alzheimer’s disease by changing levels of a protein that is present in cerebrospinal fluid. In a recent Science Translational Medicinepaper, the international team describes how variants in the MS4A4A gene influence the risk...
Posted Today While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer’s disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, according to a new study from researchers in the Perelman School of Medicine and Thomas Jefferson University. The researchers concluded that...
by Isabelle Dubach, University of New South Wales Weight training—also called resistance training—can help people with peripheral artery disease reduce painful symptoms like muscle cramps during walking, a study by UNSW medical researchers recently published in the British Journal of Sports Medicine has shown. In people with peripheral artery disease (PAD), a build-up of plaque in the arteries—caused by high cholesterol, nicotine and other cardiovascular disease risk factors—leads...
